Earnings Feed
Start Free
|4Aug 13, 6:03 PM ET

Lind Kevin Robert 4

4 · Longboard Pharmaceuticals, Inc. · Filed Aug 13, 2024

Insider Transaction Report

Form 4
Period: 2024-08-12
Longboard Pharmaceuticals, Inc.LBPH
Lind Kevin Robert
DirectorPresident and CEO
Transactions
  • Exercise/Conversion

    Common Stock

    2024-08-12$3.12/sh+80,265$250,684→ 428,715 total
  • Exercise/Conversion

    Common Stock

    2024-08-12$4.20/sh+2,217$9,311→ 430,932 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-08-12−80,265→ 268,185 total
    Exercise: $3.12Exp: 2030-10-26→ Common Stock (80,265 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-08-12−2,217→ 192,783 total
    Exercise: $4.20Exp: 2032-02-08→ Common Stock (2,217 underlying)
Footnotes (2)
  • [F1]The shares subject to the stock option vest and become exercisable in 24 equal monthly installments commencing November 27, 2022.
  • [F2]The shares subject to the stock option vest and become exercisable in 48 equal monthly installments commencing March 9, 2023.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4